Cart
0

Prefilled Syringes Market by Material (Glass-based and Plastic-based), Design (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes), Therapeutic (Large Molecules and Small Molecules), and Application [Anaphylaxis, Rheumatoid Arthritis, Diabetes, and Others (Cancer, Multiple Sclerosis, and Others)] - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_17444
Pages: 160
Jul 2017 | 4173 Views
 
Author's : Onkar Sumant and Tenzin Kunsel
Tables: 56
Charts: 30
 

Prefilled Syringes Market Overview:

The Global Prefilled Syringes Market was valued at $3,567 million in 2016, and is estimated to reach $7,212 million by 2023, registering a CAGR of 10.5% from 2017 to 2023. A “prefilled syringe” is a syringe filled with a fixed quantity of a therapeutic drug. These are novel devices used for delivering drugs with improved accuracy, affordability, efficacy, convenience, sterility, safety, and accessibility. These features make it more advantageous than traditional methods of drug delivery where glass or metal vials were used to store pharmaceutical drugs. The removal of drug from these vials was prone to contamination and increased the possibility of dosing errors. Therefore, prefilled syringes eliminate the aforementioned drawbacks, resulting in increase in their demand.

Get more information on this report: Request Sample Pages

The global prefilled syringes market is segmented based on material, design, therapeutic, application, and geography. Based on material, it is bifurcated into glass-based and plastic-based. Based on design, it is divided into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. Based on therapeutic, it is categorized into large molecules and small molecules. Based on application, the market is classified into anaphylaxis, rheumatoid arthritis, diabetes, and others (cancer, multiple sclerosis). Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Get more information on this report: Request Sample Pages

Drivers, Restraints, and Opportunities

The impact of the driving factors is expected to surpass the effect of restraints. Moreover, the technological advancements leading to higher adoption rate and untapped markets in the developing countries are expected to provide new avenues for the growth of prefilled syringes market in the near future.

Get more information on this report: Request Sample Pages

Global Prefilled Syringes Market: Key Geographic Segment

Europe accounted for the highest market share in the industry in 2016, and is expected to maintain its dominance throughout the forecast period.

The key players operating in the global prefilled syringes market include Becton, Dickinson and Company, Medtronic plc., Gerresheimer AG, Terumo Medical Corporation, West Pharmaceutical Services, Inc., Nipro Corporation, Unilife Corporation, Vetter Pharma International GmbH, Baxter International, and Abbott Laboratories.

The other prominent players in the value chain include Ypsomed Holding AG, Haselmeier, Weigao Group, Owen Mumford, Bayer Healthcare, and Biocon.

Key Benefits

  • This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • The global market is comprehensively analyzed with respect to material, design, therapeutic, application, and geography.
  • In-depth analysis based on geography assists to understand the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Prefilled Syringes Market Key Segments:

By Material

  • Glass-based
  • Plastic-based

By Design

  • Single-chamber Prefilled Syringes
  • Dual-chamber Prefilled Syringes
  • Customized Prefilled Syringes

By Therapeutic

  • Large Molecules
  • Small Molecules

By Application

  • Anaphylaxis
  • Rheumatoid Arthritis
  • Diabetes
  • Others (Cancer, Multiple Sclerosis, and others)

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Republic of South Africa
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Growth in home-based healthcare market
3.5.1.2. Increase in adoption of injectable drugs
3.5.1.3. Rise in incidence rate of chronic disease
3.5.1.4. Benefits of using prefilled syringes over conventional vials
3.5.1.5. Technological advancement

3.5.2. Restraints

3.5.2.1. Stringent government regulations
3.5.2.2. Availability of alternate drug-delivery methods
3.5.2.3. Product recalls

3.5.3. Opportunities

3.5.3.1. Rise in demand for biologics and biosimilars
3.5.3.2. Increase in demand for injectable drugs in prefilled forms

Chapter: 4 PREFILLED SYRINGES MARKET, BY MATERIAL

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. GLASS-BASED PREFILLED SYRINGES

4.2.1. Market size and forecast

4.3. PLASTIC-BASED PREFILLED SYRINGES

4.3.1. Market size and forecast

Chapter: 5 PREFILLED SYRINGES MARKET, BY DESIGN

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. SINGLE-CHAMBER PREFILLED SYRINGES

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.3. DUAL-CHAMBER PREFILLED SYRINGES

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast

5.4. CUSTOMIZED PREFILLED SYRINGES

5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast

Chapter: 6 PREFILLED SYRINGES MARKET, BY THERAPEUTICS

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. LARGE MOLECULES

6.2.1. Market size and forecast

6.3. SMALL MOLECULES

6.3.1. Market size and forecast

Chapter: 7 PREFILLED SYRINGES MARKET, BY APPLICATION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. ANAPHYLAXIS

7.2.1. Market size and forecast

7.3. RHEUMATOID ARTHRITIS

7.3.1. Market size and forecast

7.4. DIABETES

7.4.1. Market size and forecast

7.5. OTHERS APPLICATIONS

7.5.1. Market size and forecast

Chapter: 8 PREFILLED SYRINGES MARKET, BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast

8.2.3.1. U.S. market size and forecast
8.2.3.2. Mexico market size and forecast
8.2.3.3. Canada market size and forecast

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast

8.3.3.1. UK market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. Germany market size and forecast
8.3.3.4. Rest of Europe market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast

8.4.3.1. India market size and forecast
8.4.3.2. Japan market size and forecast
8.4.3.3. China market size and forecast
8.4.3.4. Rest of Asia-Pacific market size and forecast

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast

8.5.3.1. Brazil market size and forecast
8.5.3.2. South Africa market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast

Chapter: 9 COMPANY PROFILES

9.1. BECTON, DICKINSON AND COMPANY

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments

9.2. MEDTRONIC PLC

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments

9.3. GERRESHEIMER AG

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments

9.4. TERUMO MEDICAL CORPORATION

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments

9.5. WEST PHARMACEUTICAL SERVICES, INC.

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments

9.6. NIPRO CORPORATION

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments

9.7. UNILIFE CORPORATION

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments

9.8. VETTER PHARMA INTERNATIONAL GMBH

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments

9.9. BAXTER INTERNATIONAL

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments

9.10. ABBOTT LABORATORIES

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 2. GLASS-BASED PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. PLASTIC-BASED PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 5. SINGLE-CHAMBER PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. DUAL-CHAMBER PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. CUSTOMIZED PREFILLED SYRINGES, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 9. PREFILLED SYRINGES MARKET FOR LARGE MOLECULES, BY REGION, 2016-2023 ($MILLION)
TABLE 10. PREFILLED SYRINGES MARKET FOR SMALL MOLECULES, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 12. PREFILLED SYRINGES MARKET FOR ANAPHYLAXIS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. PREFILLED SYRINGES MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. PREFILLED SYRINGES MARKET FOR DIABETES, BY REGION, 2016-2023 ($MILLION)
TABLE 15. PREFILLED SYRINGES MARKET FOR OTHER APPLICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 16. PREFILLED SYRINGES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA PREFILLED SYRINGES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 22. EUROPE PREFILLED SYRINGES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23. EUROPE PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 24. EUROPE PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 25. EUROPE PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 26. EUROPE PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 27. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 29. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 32. LAMEA PREFILLED SYRINGES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 33. LAMEA PREFILLED SYRINGES MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 34. LAMEA PREFILLED SYRINGES MARKET, BY DESIGN, 2016-2023 ($MILLION)
TABLE 35. LAMEA PREFILLED SYRINGES MARKET, BY THERAPEUTICS, 2016-2023 ($MILLION)
TABLE 36. LAMEA PREFILLED SYRINGES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 37. BD: COMPANY SNAPSHOT
TABLE 38. BD: OPERATING SEGMENTS
TABLE 39. MEDTRONIC: COMPANY SNAPSHOT
TABLE 40. MEDTRONIC: OPERATING SEGMENTS
TABLE 41. GERRESHEIMER: COMPANY SNAPSHOT
TABLE 42. GERRESHEIMER: OPERATING SEGMENTS
TABLE 43. TERUMO: COMPANY SNAPSHOT
TABLE 44. TERUMO: OPERATING SEGMENTS
TABLE 45. WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
TABLE 46. WEST PHARMACEUTICAL SERVICES: OPERATING SEGMENTS
TABLE 47. NIPRO: COMPANY SNAPSHOT
TABLE 48. NIPRO: OPERATING SEGMENTS
TABLE 49. UNILIFE: COMPANY SNAPSHOT
TABLE 50. UNILIFE: OPERATING SEGMENTS
TABLE 51. VETTER: COMPANY SNAPSHOT
TABLE 52. VETTER: OPERATING SEGMENTS
TABLE 53. BAXTER: COMPANY SNAPSHOT
TABLE 54. BAXTER: OPERATING SEGMENTS
TABLE 55. ABBOTT: COMPANY SNAPSHOT
TABLE 56. ABBOTT: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. SEGMENTATION OF GLOBAL PREFILLED SYRINGES MARKET
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL PREFILLED SYRINGES MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 6. BARGAINING POWER OF BUYERS
FIGURE 7. BARGAINING POWER OF SUPPLIERS
FIGURE 8. THREAT OF NEW ENTRANTS
FIGURE 9. THREAT OF SUBSTITUTION
FIGURE 10. COMPETITIVE RIVALRY
FIGURE 11. RESTRAINTS AND DRIVERS: GLOBAL PREFILLED SYRINGES MARKET
FIGURE 12. GLOBAL PREFILLED SYRINGES MARKET: SEGMENTATION BY MATERIAL
FIGURE 13. GLOBAL PREFILLED SYRINGES MARKET: SEGMENTATION BY DESIGN
FIGURE 14. GLOBAL PREFILLED SYRINGES MARKET: SEGMENTATION BY THERAPEUTICS
FIGURE 15. GLOBAL PREFILLED SYRINGES MARKET: SEGMENTATION BY APPLICATION
FIGURE 16. U.S. PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 17. MEXICO PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 18. CANADA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 19. UK PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 20. FRANCE PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 21. GERMANY PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 22. REST OF EUROPE PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 23. INDIA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 24. JAPAN PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 25. CHINA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 27. BRAZIL PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 28. SOUTH AFRICA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 29. SAUDI ARABIA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)
FIGURE 30. REST OF LAMEA PREFILLED SYRINGES MARKET, 2016-2023 ($MILLION)

 

Prefilled syringes contain fixed doses of drugs that can be either self-administered by the patient or can be used by the healthcare professionals. Prefilled syringes are gaining acceptance in the market as drug delivery systems for injectable drugs. They are preferred for parenteral administration of various drugs and are used for the treatment of chronic diseases where self-administration of drugs by the patients is required.

The advantages of using prefilled syringes, such as reduced risk caused by using vials before use of drugs, ease of use, decreased risk of contamination, and elimination of dosing errors, have largely contributed toward their increase in demand among the healthcare professionals. Moreover, the rise in demand for home-based healthcare products, growth in incidence of chronic diseases, and increase in adoption of injectable drugs are expected to boost the market growth.

The use of prefilled syringes is highest in Europe, owing to the maturity of the market, increase in adoption of these products, high prevalence rate of chronic diseases, and increase in disposable income among customers. Although the use of prefilled syringes in Asia-Pacific and LAMEA is low, the adoption rate is expected to increase, owing to rise in disposable income, increase in incidence rate of chronic disease, and presence of large geriatric population.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Prefilled Syringes Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3690
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4099
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4999
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6004
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8373
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo